Related Experiment Video
Updated: Jun 17, 2026
06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
[Update on photoprotection in children]
M Valdivielso-Ramos1, J M Herranz
1Hospital Infanta Leonor, Madrid, España. mvaldira@yahoo.es
Anales De Pediatria (Barcelona, Spain : 2003)
|January 8, 2010
Summary
Maximizing photoprotection in children is crucial due to increased outdoor activity and cumulative ultraviolet radiation exposure, a key factor in skin cancer development. Educating children and parents on sun safety measures can significantly reduce skin cancer incidence.
Area of Science:
- Pediatric Dermatology
- Public Health
- Environmental Health
Context:
- Children engage in more outdoor activities, increasing their susceptibility to ultraviolet (UV) radiation.
- Cumulative UV exposure during childhood is a primary risk factor for all types of skin cancer.
- Effective photoprotection strategies are essential for long-term skin health in pediatric populations.
Purpose:
- To review current knowledge on pediatric sun protection strategies.
- To highlight the importance of early and consistent sun safety education for children.
- To discuss advancements in sunscreens and educational programs for enhancing photoprotection.
Summary:
- Photoprotection is paramount in children due to higher sun exposure and the long-term risks of UV radiation, including skin cancer.
- Key protective measures include behavioral strategies like protective clothing, hats, sunglasses, and sunscreen application.
- Educational campaigns targeting parents and children, supported by dermatologists and pediatricians, are vital for increasing awareness and promoting sun-safe attitudes.
Impact:
- Implementing effective pediatric photoprotection can significantly decrease the future incidence of various skin cancers.
- Enhanced understanding and adoption of sun safety practices can lead to a healthier skin profile in adulthood.
- Disseminating information on new sunscreens and educational programs can improve the efficacy of public health initiatives for children's sun protection.
More Related Videos
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:19Pigmentation
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...